Debt-to-equity of IGM Biosciences, Inc. from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IGM Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2020 to 30 Jun 2025.
  • IGM Biosciences, Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 287%, a 144% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IGM Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 287% +169% +144% 30 Jun 2025
Q1 2025 345% +245% +245% 31 Mar 2025
Q4 2024 212% +120% +129% 31 Dec 2024
Q3 2024 155% +69% +80% 30 Sep 2024
Q2 2024 117% +38% +48% 30 Jun 2024
Q1 2024 100% +29% +42% 31 Mar 2024
Q4 2023 93% +34% +59% 31 Dec 2023
Q3 2023 86% +40% +88% 30 Sep 2023
Q2 2023 79% +47% +145% 30 Jun 2023
Q1 2023 71% +54% +312% 31 Mar 2023
Q4 2022 58% +46% +362% 31 Dec 2022
Q3 2022 46% +36% +385% 30 Sep 2022
Q2 2022 32% +24% +291% 30 Jun 2022
Q1 2022 17% +9% +99% 31 Mar 2022
Q4 2021 13% +4% +38% 31 Dec 2021
Q3 2021 9% -1% -5.9% 30 Sep 2021
Q2 2021 8% 0% -1.1% 30 Jun 2021
Q1 2021 9% 31 Mar 2021
Q4 2020 9% 31 Dec 2020
Q3 2020 10% 30 Sep 2020
Q2 2020 8% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.